Article | August 8, 2023

The Incubation Shaker Advancing mRNA Vaccine Development

Source: INFORS HT

By Melissa Chen Montes de Oca

GettyImages-533059254-mRNA_DNA_gene_therapy

mRNA technology is driving forward innovative vaccines and therapeutics by taking a different approach in how they interact with immune systems. Traditional vaccines often involve introducing weakened or inactivated pathogens to stimulate an immune response, while mRNA vaccines deliver a small piece of synthetic mRNA that encodes a viral protein. This mRNA method was used in the development of COVID-19 vaccines and has since been explored in relation to the field of cancer therapies.

Alongside the great promise of mRNA vaccine development, comes a list of unique challenges to overcome. Researchers are tackling these challenges while striving for a shorter time to market that will patients.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online